Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPL-2009-0031 vs Sitagliptin in Uncontrolled T2DM
NCT04801199Phase 3Completed
- Sponsor
- Cadila Pharmaceuticals
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CPL-2009-0031 in type 2 diabetes mellitus (T2DM), sponsored by Cadila Pharmaceuticals. Started Jan 2020; status: completed.
02
Drugs
CPL-2009-0031
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04801199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801199.